Skip to main content
logo
Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
6.24
+0.04 (0.65%)
Sep 8, 2026, 12:19 PM EDT - Market open

Niki BioSolutions Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.431.31.54
Revenue Growth
----66.71%-15.95%69.15%
Gross Profit
---0.010.080.08
Operating Income
-2.83-1.82-2.45-10.12-17.51-19.21
Net Income
-2.25-1.36-4.27-2.82-9.8-25.05
Earnings Per Share
-2.86-1.85-7.83-6.25-27.50-71.50
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.833.450.872.011.998.37
Total Debt
3.513.443.353.286.850.22
Net Cash (Debt)
-1.670.01-2.48-1.28-4.878.15
Net Cash Growth
------72.08%
Net Cash Per Share
-2.130.01-4.55-2.83-13.6423.27

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.57-1.84-1.19-7.72-12.32-14.65
Capital Expenditures
----0-0.19-0.13
Free Cash Flow
-2.57-1.84-1.19-7.73-12.51-14.78
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---2.45%6.18%5.31%
Operating Margin
----2347.11%-1351.13%-1245.77%
Pretax Margin
----1006.30%-889.36%-1758.64%
Profit Margin
----654.80%-756.20%-1624.64%
FCF Margin
----1791.32%-965.04%-958.85%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---29.4115.1634.66